Perspective Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $234 | $342 | $0 | $0 |
Gross Profit | -475 | -390 | ||
EBITDA | -41,498 | -17,317 | -43,959 | -14,384 |
EBIT | -42,207 | -18,049 | -44,680 | -15,053 |
Net Income | -40,169 | -18,177 | -40,169 | -15,122 |
Net Change In Cash | 234 | 342 | 0 | 0 |
Free Cash Flow | -18,642 | -26,238 | -41,220 | -26,347 |
Cash | 28,849 | 44,406 | 61,580 | 226,443 |
Basic Shares | 70,671 | 72,357 | 70,629 | 70,629 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,434 | $7,104 | $7,104 |
Gross Profit | 1,434 | 1,634 | 1,634 | |
EBITDA | 10,459 | -39,960 | -14,838 | -14,838 |
EBIT | -40,941 | -15,182 | -15,182 | |
Net Income | -79,279 | -46,508 | -14,670 | -14,670 |
Net Change In Cash | 0 | 1,434 | 7,104 | 7,104 |
Free Cash Flow | -72,708 | -37,985 | -12,474 | -12,474 |
Cash | 61,580 | 9,238 | 20,993 | 20,993 |
Basic Shares | 64,425 | 54,905 | 142,103 | 54,905 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.29 |
2025-03-31 | -$0.25 |
2024-12-31 | -$0.57 |
